Item 5. Market for Registrant’s Common Equity
ITEM 5. MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS
Our common stock is quoted on the OTC Markets, OTCQB, under the symbol “FCCN.” We have applied to list our Common Stock on the Nasdaq Capital Market under the symbol “FCCN.”
The following table sets forth the high and low bid prices per share for our common stock for the quarterly periods indicated. The prices represent inter-dealer quotations, do not include retail markups, markdowns, or commissions, and may not represent actual transactions.
FCCN – Quarterly High / Low Table (2024–2025)
Year
Quarter
Quarterly High
Quarterly Low
2024
Q3 (Jul–Sep)
5.31
2.55
2024
Q4 (Oct–Dec)
6.20
3.23
2025
Q1 (Jan–Mar)
11.30
3.09
2025
Q2 (Apr–Jun)
4.01
2.00
2025
Q3 (Jul–Sep)
3.33
1.60
2025
Q4 (Oct–Dec)
4.35
1.81
Holders of Common Stock
As of March 31, 2026 there were approximately 163 holders of record of our common stock. As of such date, there were 89,354,216 shares of our Common Stock issued and outstanding.
Dividends
We have never paid any cash dividends on our common stock and do not anticipate paying any cash dividends in the foreseeable future. We plan to retain any future earnings to finance growth and development of our business. Any future determination to pay cash dividends will be at the discretion of our Board of Directors, subject to applicable laws, and will be dependent upon our earnings, financial condition, operating results, capital requirements, any contractual restrictions, and other factors that our Board of Directors deems relevant.
Recent Sales of Unregistered Securities
Subsequent to the fiscal year ended December 31, 2025, on March 13, 2026, the Company issued 100,000 shares of common stock at a price of $2.00 per share to one accredited investor in a private placement for aggregate proceeds of $200,000. The issuance was made in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506(b) of Regulation D promulgated thereunder. No underwriters were involved. The shares bear a restrictive legend and have not been registered under the Securities Act.
For a description of unregistered securities issued during the fiscal year ended December 31, 2025, see Note 12 — Stockholders’ Equity in the consolidated financial statements included in this Annual Report.
ITEM 6. [Reserved]
40
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.